SOVERINI, SIMONA

SOVERINI, SIMONA  

DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE  

Docenti di ruolo di IIa fascia  

Simona Soverini; SOVERINI S.; Soverini Simona; S. SOVERINI  

Mostra records
Risultati 1 - 20 di 333 (tempo di esecuzione: 0.036 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis Sciumè, Mariarita; Serpenti, Fabio; Zanotti, Roberta; Bonadonna, Patrizia; Tanasi, Ilaria; Croser...a, Lara; Elena, Chiara; Mannelli, Francesco; Crupi, Francesca; Papayannidis, Cristina; Sartor, Chiara; Soverini, Simona; Rondoni, Michela; Eller‐Vainicher, Cristina; Pravettoni, Valerio; Rivolta, Federica; Alberti Violetti, Silvia; Croci, Giorgio Alberto; Migliorini, Anna Chiara; Bolli, Niccolò; Giannarelli, Diana; Grifoni, Federica Irene 2024-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -
European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia Cross N.C.P.; Ernst T.; Branford S.; Cayuela J.-M.; Deininger M.; Fabarius A.; Kim D.D.H.; Machov...a Polakova K.; Radich J.P.; Hehlmann R.; Hochhaus A.; Apperley J.F.; Soverini S. 2023-01-01 LEUKEMIA - 1.01 Articolo in rivista s41375-023-02048-y-4.pdf
Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights Iezza M.; Cortesi S.; Ottaviani E.; Mancini M.; Venturi C.; Monaldi C.; De Santis S.; Testoni N.;... Soverini S.; Rosti G.; Cavo M.; Castagnetti F. 2023-01-01 CELLS - 1.01 Articolo in rivista cells-12-01703-v2.pdf
Resistance mutations in CML and how we approach them Soverini S. 2023-01-01 - - 4.01 Contributo in Atti di convegno -
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted Mancini M.; Monaldi C.; De Santis S.; Papayannidis C.; Rondoni M.; Sartor C.; Bruno S.; Pagano L....; Criscuolo M.; Zanotti R.; Bonifacio M.; Tosi P.; Arock M.; Valent P.; Cavo M.; Soverini S. 2023-01-01 BIOMARKER RESEARCH - 1.01 Articolo in rivista Mancini_2023.pdf40364_2023_468_MOESM1_ESM.docx
CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies Bruno S.; Ghelli Luserna di Rora A.; Napolitano R.; Soverini S.; Martinelli G.; Simonetti G. 2022-01-01 JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH - 1.01 Articolo in rivista Bruno_JECCR_2022.pdf13046_2022_2363_MOESM1_ESM.docx
CML-184 A Novel Droplet Digital PCR Strategy for Rapid and Sensitive Detection of BCR::ABL1 Kinase Domain Mutations Conferring Resistance to Second-Generation Tyrosine Kinase Inhibitors de Santis S.; Monaldi C.; Martelli M.; Mancini M.; Bruno S.; Castagnetti F.; Gugliotta G.; Polako...va K.M.; Ernst T.; Maar D.; Corner A.; Cavo M.; Soverini S. 2022-01-01 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA - 1.01 Articolo in rivista -
Combined Inhibition of Polo-like Kinase-1 and Wee1 as a New Therapeutic Strategy to Induce Apoptotic Cell Death in Neoplastic Mast Cells Mancini M.; Monaldi C.; De Santis S.; Rondoni M.; Papayannidis C.; Sartor C.; Curti A.; Bruno S.;... Cavo M.; Soverini S. 2022-01-01 CANCERS - 1.01 Articolo in rivista cancers-14-00738.pdfcancers-14-00738-s001.zip
Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia Soverini S.; De Santis S.; Martelli M.; Monaldi C.; Castagnetti F.; Gugliotta G.; Papayannidis C....; Mancini M.; Bruno S.; Venturi C.; Machova Polakova K.; Ernst T.; Maar D.; Corner A.; Cavo M. 2022-01-01 LEUKEMIA - 1.01 Articolo in rivista -
MPN-182 Droplet Digital PCR for Non-Invasive Detection of the KIT D816V Mutation in the Peripheral Blood of Patients With Suspected Systemic Mastocytosis Monaldi C.; de Santis S.; Mancini M.; Papayannidis C.; Sartor C.; Rondoni M.; Bruno S.; Cavo M.; ...Soverini S. 2022-01-01 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA - 1.01 Articolo in rivista -
Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia De Santis S.; Monaldi C.; Mancini M.; Bruno S.; Cavo M.; Soverini S. 2022-01-01 ONCOTARGETS AND THERAPY - 1.01 Articolo in rivista OTT-289306-overcoming-resistance-to-kinase-inhibitors--the-paradigm-of-.pdf
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B....; Rosti G.; Cavo M.; Gugliotta G.; Soverini S. 2022-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista fonc-12-901132.pdffile supplementari.zip
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia Baccarani M.; Bonifazi F.; Soverini S.; Castagnetti F.; Gugliotta G.; Saber W.; Estrada-Merly N.;... Rosti G.; Gale R.P. 2022-01-01 LEUKEMIA - 1.01 Articolo in rivista Baccarani_Leukemia_2022.pdf
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year followup of the GIMEMA CML 0307 study Gugliotta G.; Castagnetti F.; Breccia M.; Levato L.; Intermesoli T.; D'Adda M.; Salvucci M.; Stag...no F.; Rege-Cambrin G.; Tiribelli M.; Martino B.; Bocchia M.; Cedrone M.; Trabacchi E.; Cavazzini F.; Porretto F.; Sora F.; Simula M.P.; Albano F.; Soverini S.; Foa R.; Pane F.; Cavo M.; Saglio G.; Baccarani M.; Rosti G. 2022-01-01 HAEMATOLOGICA - 1.01 Articolo in rivista 10596-Article Text-77970-2-10-20220928.pdf2021_280175_GUGLIOTTA_SUPPL.pdf
Assessment of individual molecular response in chronic myeloid leukemia patients with atypical BCR-ABL1 fusion transcripts: recommendations by the EUTOS cooperative network Schafer V.; White H.E.; Gerrard G.; Mobius S.; Saussele S.; Franke G.-N.; Mahon F.-X.; Talmaci R....; Colomer D.; Soverini S.; Machova Polakova K.; Cross N.C.P.; Hochhaus A.; Ernst T. 2021-01-01 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY - 1.01 Articolo in rivista Schäfer2021_Article_AssessmentOfIndividualMolecula(1).pdf432_2021_3569_MOESM1_ESM.pdf
BCR-ABL1 compound mutants: prevalence, spectrum and correlation with tyrosine kinase inhibitor resistance in a consecutive series of Philadelphia chromosome-positive leukemia patients analyzed by NGS Soverini S.; Martelli M.; Bavaro L.; De Benedittis C.; Sica S.; Sora F.; Iurlo A.; Bonifacio M.; ...Pregno P.; Galimberti S.; Lunghi F.; Albano F.; D'Adda M.; Crugnola M.; Capodanno I.; Castagnetti F.; Gugliotta G.; Papayannidis C.; Rosti G.; Percesepe A.; Mignone F.; Baccarani M.; Martinelli G.; Cavo M. 2021-01-01 LEUKEMIA - 1.01 Articolo in rivista -
Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia Bruno S.; Bandini L.; Patuelli A.; Robustelli V.; Venturi C.; Mancini M.; Forte D.; De Santis S.;... Monaldi C.; Grassi A.; Chiurumbolo G.; Paolini S.; Cristiano G.; Papayannidis C.; Sartor C.; Nanni J.; Ottaviani E.; Curti A.; Cavo M.; Soverini S. 2021-01-01 FRONTIERS IN ONCOLOGY - 1.01 Articolo in rivista fonc-11-728613.pdf
Improving prognostication and management of systemic mastocytosis Soverini S. 2021-01-01 THE LANCET. HAEMATOLOGY - 1.03 Recensione in rivista -
INCB84344-201: Ponatinib and steroids in frontline therapy of unfit patients with Ph+ acute lymphoblastic leukemia Martinelli, Giovanni; Papayannidis, Cristina; Piciocchi, Alfonso; Robustelli, Valentina; Soverini..., Simona; Terragna, Carolina; Marconi, Giovanni; Lemoli, Roberto Massimo; Guolo, Fabio; Fornaro, Antonella; Lunghi, Monia; de Fabritiis, Paolo; Candoni, Anna; Selleri, Carmine; Simonetti, Federico; Bocchia, Monica; Vitale, Antonella; Frison, Luca; Tedeschi, Alessandra; Cuneo, Antonio; Bonifacio, Massimiliano; Martelli, Maria Paola; D'Ardia, Stefano; Trappolini, Silvia; Tosi, Patrizia; Galieni, Piero; Fabbiano, Francesco; Abbenante, Maria Chiara; Granier, Muriel; Zhu, Zhaoyin; Wang, Mingyue; Sartor, Chiara; Paolini, Stefania; Cavo, Michele; Foà, Robin; Fazi, Paola; Vignetti, Marco; Baccarani, Michele 2021-01-01 BLOOD ADVANCES - 1.01 Articolo in rivista Martinelli_Blood Adv 2022.pdf
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant Papayannidis C.; Sartor C.; Dominietto A.; Zappone E.; Arpinati M.; Marconi G.; Cristiano G.; Nan...ni J.; Parisi S.; Barbato F.; Paolini S.; Soverini S.; Terragna C.; Robustelli V.; Testoni N.; Chirumbolo G.; Curti A.; Cavo M.; Bonifazi F. 2021-01-01 HEMATOLOGICAL ONCOLOGY - 1.01 Articolo in rivista -